SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-113553
Filing Date
2024-11-01
Accepted
2024-11-01 17:24:13
Documents
13
Period of Report
2024-10-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2420750d1_8k.htm   iXBRL 8-K 23851
  Complete submission text file 0001104659-24-113553.txt   194624

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION LABEL LINKBASE nwbo-20241031_lab.xml EX-101.LAB 34240
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nwbo-20241031_pre.xml EX-101.PRE 22353
4 XBRL TAXONOMY EXTENSION SCHEMA nwbo-20241031.xsd EX-101.SCH 3006
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2420750d1_8k_htm.xml XML 3584
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35737 | Film No.: 241420086
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)